AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Genmab Earnings Release 2010

Feb 28, 2011

Preview isn't available for this file type.

Download source file

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

-- Achieved lowest operating loss in ten years of DKK 161 million
-- Increased cash in 2010 by DKK 265 million to DKK 1,546 million
-- Lowered operating expenses to DKK 743 million, beating previous guidance,
further reductions guided in 2011
-- Increase in Arzerra royalties by 48% to a projected DKK 80 million in 2011

In order to read Genmab's Financial Statements Release 2010 please see the
attached file.

Contact:
Helle Husted, Vice President, Investor Relations
T: +45 33 44 77 30
M: +45 25 27 47 13
E: [email protected]
www.genmab.com

Stock Exchange Release no. 03
CVR no. 2102 3884

Genmab A/S
Bredgade 34
1260 Copenhagen K
Denmark

AI assistant

Genmab — Earnings Release 2010

More from Genmab

Genmab Earnings Release 2010